What Is Driving Vystar Corp (OTCMKTS:VYST) Stock?
Post# of 1208
(Total Views: 335)
Posted On: 03/06/2020 11:22:53 AM
What Is Driving Vystar Corp (OTCMKTS:VYST) Stock?
ByJim BloomPosted on February 26, 2020
Vystar Corp (OTCMKTS:VYST) is the small-cap stock that has become the big talk of the OTC Markets in recent days. Vystar has a market cap of about $10 million, rapidly growing sales, a strong balance sheet, and most of all, bright prospects.
Investors are showing really huge appetite for Vystar shares, which have now risen about 1,200% from their 2019 low. The stock rose 27% in the last session to wrap up the day at $0.0089. Notably, more than 8.8 million shares change hands in the last session, marking Vystar’s biggest single-day trading volume so far this year. The sharp spike in volume no doubt points to the rapidly improving investor sentiment around the stock.
There is a lot that is exciting about OTCMKTS:VYST and we’ve discussed all that in this report. You will find out why now may be the best time to take a position in Vystar, particularly taking advantage of the still depressed share price before the coming big breakout. But before we get into the details, here’s a brief profile of Vystar for those investors who may be coming across this company for the very first time.
VYST Daily Chart
ABOUT VYSTAR CORP (OTCMKTS:VYST)
Vystar is an American company with a diversified operation portfolio. The company is into natural rubber latex business and has created a patented product called Vytex. Vytex is an eco-friendly raw material used in a range of domestic, office and hospital products. In the hospital space, Vytex is used in medical devices as well as surgical and exam gloves. Vystar also makes air purification products under the RxAir brand for homes, offices and hospitals. Additionally, Vystar is into clean energy and furniture businesses.
The coronavirus outbreak in China that is now spreading around the world has created a perfect business opportunity for Vystar. The demand for hygiene products that Vystar makes are in high demand as the world battles the deadly coronavirus outbreak.
Being a small company, Vystar did not quickly capture investors’ attention as they pursued stocks of suppliers likely to benefit from the coronavirus outbreak. Now the word is getting out about Vystar and how it stands to reap from the efforts to curb the spread of the virus and that is attracting more investors to the stock.
CORONAVIRUS OUTBREAK JUST BOOSTED DEMAND FOR VYSTAR’S RUBBER GLOVES MATERIAL
The demand for hygiene items such as rubber gloves has spiked all over the world in the wake of the coronavirus outbreak. The virus is highly contagious and is spreading rapidly. It has infected more than 80,000 people and killed nearly 3,000 people, mostly in China. That has resulted in the big rush for rubber gloves as hospitals take measures to ensure that they have enough supplies of safety gloves for their doctors to handle coronavirus patients.
Vystar supplies high-quality natural rubber material called Vytex that is used in the making of gloves for hospitals use. Therefore, the company stands to benefit from the spike in demand for rubber gloves caused by the coronavirus outbreak. Additionally, Vystar could benefit from better prices for its Vytex product. Fears about looming shortage of rubber is forcing makers of rubber gloves to make big orders for the raw material to ensure they have enough to run their operations.
BOOM FOR VYSTAR’S AIR PURIFIER BUSINESS AS CORONAVIRUS DRIVES DEMAND
The coronavirus outbreak has renewed demand for air purifiers. The virus is spread through the air and it affects people’s respiratory system. To curb the spread of the deadly virus, people are turning to air purifiers to try to kill the virus that may be present in the air around them. Vystar makes air purifiers for homes, offices and hospitals under its RxAir brand. Therefore, the company stands to reap big from the the coronavirus-induced demand for air purifiers. The global air purifier market is on track to hit $18.2 billion in 2027 from $8.0 billion in 2019.
OTCMKTS:VYST STANDS ON SOLID FINANCIAL GROUNDS
Vystar generated revenue of more than $6.0 million in the third quarter of 2019, marking a big increase from revenue of just $186,000 in the second quarter. Revenue could soar this year as Vystar fills coronavirus-induced demand for its products. The company has $22.5 million in assets and just $3.2 million in long-term debt.
BOTTOM LINE
Vystar stock looks destined for greater highs. Trading at $0.0089 currently, the stock is going for a big discount to last year’s high of $.1580 a share.
We will be updating our subscribers as soon as we know more. For the latest updates on OTCMKTS:VYST, sign up below!
Disclosure: We have no position in OTCMKTS:VYST and have not been compensated for this article.
ByJim BloomPosted on February 26, 2020
Vystar Corp (OTCMKTS:VYST) is the small-cap stock that has become the big talk of the OTC Markets in recent days. Vystar has a market cap of about $10 million, rapidly growing sales, a strong balance sheet, and most of all, bright prospects.
Investors are showing really huge appetite for Vystar shares, which have now risen about 1,200% from their 2019 low. The stock rose 27% in the last session to wrap up the day at $0.0089. Notably, more than 8.8 million shares change hands in the last session, marking Vystar’s biggest single-day trading volume so far this year. The sharp spike in volume no doubt points to the rapidly improving investor sentiment around the stock.
There is a lot that is exciting about OTCMKTS:VYST and we’ve discussed all that in this report. You will find out why now may be the best time to take a position in Vystar, particularly taking advantage of the still depressed share price before the coming big breakout. But before we get into the details, here’s a brief profile of Vystar for those investors who may be coming across this company for the very first time.
VYST Daily Chart
ABOUT VYSTAR CORP (OTCMKTS:VYST)
Vystar is an American company with a diversified operation portfolio. The company is into natural rubber latex business and has created a patented product called Vytex. Vytex is an eco-friendly raw material used in a range of domestic, office and hospital products. In the hospital space, Vytex is used in medical devices as well as surgical and exam gloves. Vystar also makes air purification products under the RxAir brand for homes, offices and hospitals. Additionally, Vystar is into clean energy and furniture businesses.
The coronavirus outbreak in China that is now spreading around the world has created a perfect business opportunity for Vystar. The demand for hygiene products that Vystar makes are in high demand as the world battles the deadly coronavirus outbreak.
Being a small company, Vystar did not quickly capture investors’ attention as they pursued stocks of suppliers likely to benefit from the coronavirus outbreak. Now the word is getting out about Vystar and how it stands to reap from the efforts to curb the spread of the virus and that is attracting more investors to the stock.
CORONAVIRUS OUTBREAK JUST BOOSTED DEMAND FOR VYSTAR’S RUBBER GLOVES MATERIAL
The demand for hygiene items such as rubber gloves has spiked all over the world in the wake of the coronavirus outbreak. The virus is highly contagious and is spreading rapidly. It has infected more than 80,000 people and killed nearly 3,000 people, mostly in China. That has resulted in the big rush for rubber gloves as hospitals take measures to ensure that they have enough supplies of safety gloves for their doctors to handle coronavirus patients.
Vystar supplies high-quality natural rubber material called Vytex that is used in the making of gloves for hospitals use. Therefore, the company stands to benefit from the spike in demand for rubber gloves caused by the coronavirus outbreak. Additionally, Vystar could benefit from better prices for its Vytex product. Fears about looming shortage of rubber is forcing makers of rubber gloves to make big orders for the raw material to ensure they have enough to run their operations.
BOOM FOR VYSTAR’S AIR PURIFIER BUSINESS AS CORONAVIRUS DRIVES DEMAND
The coronavirus outbreak has renewed demand for air purifiers. The virus is spread through the air and it affects people’s respiratory system. To curb the spread of the deadly virus, people are turning to air purifiers to try to kill the virus that may be present in the air around them. Vystar makes air purifiers for homes, offices and hospitals under its RxAir brand. Therefore, the company stands to reap big from the the coronavirus-induced demand for air purifiers. The global air purifier market is on track to hit $18.2 billion in 2027 from $8.0 billion in 2019.
OTCMKTS:VYST STANDS ON SOLID FINANCIAL GROUNDS
Vystar generated revenue of more than $6.0 million in the third quarter of 2019, marking a big increase from revenue of just $186,000 in the second quarter. Revenue could soar this year as Vystar fills coronavirus-induced demand for its products. The company has $22.5 million in assets and just $3.2 million in long-term debt.
BOTTOM LINE
Vystar stock looks destined for greater highs. Trading at $0.0089 currently, the stock is going for a big discount to last year’s high of $.1580 a share.
We will be updating our subscribers as soon as we know more. For the latest updates on OTCMKTS:VYST, sign up below!
Disclosure: We have no position in OTCMKTS:VYST and have not been compensated for this article.
(0)
(0)Vystar Corp (VYST) Stock Research Links
WORDS TO LIVE BY:
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Never argue with stupid people, they will drag you down to their level and then beat you with experience.
Get .... PrivacyLok https://cyberidguard.com/
Try SafeVchat: https://cyberidguard.com/
My comments are only my opinion and are not to be used for investment advice.
Please conduct your own due diligence before choosing to buy or sell any stock.
Scroll down for more posts ▼